5 reasons to care about Ackman's Botox bet
April 22, 2014 at 16:00 PM EDT
Bill Ackman's tag-team effort to acquire the company behind Botox is raising eyebrows in financial circles.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.